MindWalk Holdings (HYFT) Current Assets (2020 - 2026)
MindWalk Holdings (HYFT) posted quarterly Current Assets of $11.8 million for Q2 2026, down 10.22% year-over-year from $13.2 million in Q2 2025, and down 12.72% quarter-over-quarter from $13.6 million in Q1 2026.
MindWalk Holdings (HYFT) Current Assets (2020 - 2026) Analysis & Trends
MindWalk Holdings (HYFT) has reported Current Assets for 7 consecutive years, with $11.8 million the latest figure, recorded in Q2 2026.
- In Q2 2026, Current Assets fell 10.22% year-over-year to $11.8 million; the TTM figure through Apr 2026 stood at $11.8 million (down 10.22% YoY), while the FY2026 annual figure was $11.8 million, down 12.11% from the prior year.
- Current Assets fell to $11.8 million in Q2 2026 per HYFT's latest filing, from $13.6 million in the prior quarter.
- Across five years, Current Assets topped out at $32.0 million in Q1 2022 and bottomed at $8.0 million in Q3 2024.
- Historically, Current Assets has averaged $15.6 million across 5 years, with a median of $13.4 million in 2025.
- Annual changes were most pronounced in 2023 — Current Assets plunged 58.05% — and 2025, when it soared 227.91%.
- MindWalk Holdings' Current Assets stood at $17.1 million in 2022, then sank by 33.47% to $11.4 million in 2023, then declined by 19.42% to $9.2 million in 2024, then soared by 71.17% to $15.7 million in 2025, then fell by 24.49% to $11.8 million in 2026.
- Business Quant data shows HYFT's Current Assets at $11.8 million in Q2 2026, $13.6 million in Q1 2026, and $15.7 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 12.54 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 18.45 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 8.07 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 4.03 Bn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 7.22 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 11.83 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 1.76 Bn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 4.62 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 1.63 Bn |
| 10 | Roivant Sciences | 26.16 Bn | 26.85 Bn | 1.16 Mn | 4.74 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 30, 2026 | 11.83 Mn |
| Jan 31, 2026 | 13.56 Mn |
| Oct 31, 2025 | 15.67 Mn |
| Jul 31, 2025 | 26.39 Mn |
| Apr 30, 2025 | 13.18 Mn |
| Jan 31, 2025 | 14.61 Mn |
| Oct 31, 2024 | 9.16 Mn |
| Jul 31, 2024 | 8.05 Mn |
| Apr 30, 2024 | 8.47 Mn |
| Jan 31, 2024 | 11.14 Mn |
| Oct 31, 2023 | 11.36 Mn |
| Jul 31, 2023 | 11.78 Mn |
| Apr 30, 2023 | 12.41 Mn |
| Jan 31, 2023 | 13.99 Mn |
| Oct 31, 2022 | 17.08 Mn |
| Jul 31, 2022 | 21.06 Mn |
| Apr 30, 2022 | 29.58 Mn |
| Jan 31, 2022 | 32.04 Mn |
| Oct 31, 2021 | 34.95 Mn |
| Jul 31, 2021 | 38.11 Mn |